APO Research, Inc.

APO RESEARCH · REPORT

Molecular Diagnostic Reagent

Selected research

Market Structure

Global Molecular Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Molecular Diagnostic Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Molecular Diagnostic Reagent include Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Roche Diagnostics, Siemens AG, Qiagen, Illumina, Hologic and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Molecular Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Diagnostic Reagent Segment by Company

Abbott Laboratories

Thermo Fisher Scientific

Merck KGaA

Roche Diagnostics

Siemens AG

Qiagen

Illumina

Hologic

Grifols

Diasorin

Danaher Corporation

DaAn Gene

Bio-Rad Laboratories

Biomérieux Sa

Becton, Dickinson and Company

Agilent Technologies

Molecular Diagnostic Reagent Segment by Type

Polymerase Chain Reaction PCR

Gene chip

Gene Sequencing

Molecular Hybridization

Molecular Diagnostic Reagent Segment by Application

Infectious Disease Diagnosis

Genetic Diagnosis

Blood Screening

Other

Molecular Diagnostic Reagent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molecular Diagnostic Reagent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Molecular Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Molecular Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Molecular Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Molecular Diagnostic Reagent Industry Trends Table 2. Molecular Diagnostic Reagent Industry Drivers Table 3. Molecular Diagnostic Reagent Industry Opportunities and Challenges Table 4. Molecular Diagnostic Reagent Industry Restraints Table 5. Global Molecular Diagnostic Reagent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Molecular Diagnostic Reagent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Molecular Diagnostic Reagent Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Molecular Diagnostic Reagent Sales Market Share by Manufacturers Table 9. Global Molecular Diagnostic Reagent Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Molecular Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Molecular Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Molecular Diagnostic Reagent Manufacturers, Product Type & Application Table 13. Global Molecular Diagnostic Reagent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Molecular Diagnostic Reagent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polymerase Chain Reaction PCR Table 17. Major Manufacturers of Gene chip Table 18. Major Manufacturers of Gene Sequencing Table 19. Major Manufacturers of Molecular Hybridization Table 20. Global Molecular Diagnostic Reagent Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Molecular Diagnostic Reagent Sales by Type (2021-2026) & (Tons) Table 22. Global Molecular Diagnostic Reagent Sales by Type (2027-2032) & (Tons) Table 23. Global Molecular Diagnostic Reagent Sales Market Share by Type (2021-2026) Table 24. Global Molecular Diagnostic Reagent Sales Market Share by Type (2027-2032) Table 25. Global Molecular Diagnostic Reagent Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Molecular Diagnostic Reagent Revenue by Type (2021-2026) & (Tons) Table 27. Global Molecular Diagnostic Reagent Revenue by Type (2027-2032) & (Tons) Table 28. Global Molecular Diagnostic Reagent Revenue Market Share by Type (2021-2026) Table 29. Global Molecular Diagnostic Reagent Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Infectious Disease Diagnosis Table 31. Major Manufacturers of Genetic Diagnosis Table 32. Major Manufacturers of Blood Screening Table 33. Major Manufacturers of Other Table 34. Global Molecular Diagnostic Reagent Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Molecular Diagnostic Reagent Sales by Application (2021-2026) & (Tons) Table 36. Global Molecular Diagnostic Reagent Sales by Application (2027-2032) & (Tons) Table 37. Global Molecular Diagnostic Reagent Sales Market Share by Application (2021-2026) Table 38. Global Molecular Diagnostic Reagent Sales Market Share by Application (2027-2032) Table 39. Global Molecular Diagnostic Reagent Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 40. Global Molecular Diagnostic Reagent Revenue by Application (2021-2026) & (Tons) Table 41. Global Molecular Diagnostic Reagent Revenue by Application (2027-2032) & (Tons) Table 42. Global Molecular Diagnostic Reagent Revenue Market Share by Application (2021-2026) Table 43. Global Molecular Diagnostic Reagent Revenue Market Share by Application (2027-2032) Table 44. Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Molecular Diagnostic Reagent Sales by Region (2021-2026) & (Tons) Table 46. Global Molecular Diagnostic Reagent Sales Market Share by Region (2021-2026) Table 47. Global Molecular Diagnostic Reagent Sales Forecasted by Region (2027-2032) & (Tons) Table 48. Global Molecular Diagnostic Reagent Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. North America Molecular Diagnostic Reagent Sales by Country (2021-2026) & (Tons) Table 51. North America Molecular Diagnostic Reagent Sales by Country (2027-2032) & (Tons) Table 52. Europe Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Europe Molecular Diagnostic Reagent Sales by Country (2021-2026) & (Tons) Table 54. Europe Molecular Diagnostic Reagent Sales by Country (2027-2032) & (Tons) Table 55. Asia Pacific Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Asia Pacific Molecular Diagnostic Reagent Sales by Country (2021-2026) & (Tons) Table 57. Asia Pacific Molecular Diagnostic Reagent Sales by Country (2027-2032) & (Tons) Table 58. South America, Middle East and Africa Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. South America, Middle East and Africa Molecular Diagnostic Reagent Sales by Country (2021-2026) & (Tons) Table 60. South America, Middle East and Africa Molecular Diagnostic Reagent Sales by Country (2027-2032) & (Tons) Table 61. Global Molecular Diagnostic Reagent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Molecular Diagnostic Reagent Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Molecular Diagnostic Reagent Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Molecular Diagnostic Reagent Revenue Market Share by Region (2021-2026) Table 65. Global Molecular Diagnostic Reagent Revenue Market Share by Region (2027-2032) Table 66. Abbott Laboratories Company Information Table 67. Abbott Laboratories Business Overview Table 68. Abbott Laboratories Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio Table 70. Abbott Laboratories Recent Development Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Merck KGaA Company Information Table 77. Merck KGaA Business Overview Table 78. Merck KGaA Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck KGaA Molecular Diagnostic Reagent Product Portfolio Table 80. Merck KGaA Recent Development Table 81. Roche Diagnostics Company Information Table 82. Roche Diagnostics Business Overview Table 83. Roche Diagnostics Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio Table 85. Roche Diagnostics Recent Development Table 86. Siemens AG Company Information Table 87. Siemens AG Business Overview Table 88. Siemens AG Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Siemens AG Molecular Diagnostic Reagent Product Portfolio Table 90. Siemens AG Recent Development Table 91. Qiagen Company Information Table 92. Qiagen Business Overview Table 93. Qiagen Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Qiagen Molecular Diagnostic Reagent Product Portfolio Table 95. Qiagen Recent Development Table 96. Illumina Company Information Table 97. Illumina Business Overview Table 98. Illumina Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Illumina Molecular Diagnostic Reagent Product Portfolio Table 100. Illumina Recent Development Table 101. Hologic Company Information Table 102. Hologic Business Overview Table 103. Hologic Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Hologic Molecular Diagnostic Reagent Product Portfolio Table 105. Hologic Recent Development Table 106. Grifols Company Information Table 107. Grifols Business Overview Table 108. Grifols Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Grifols Molecular Diagnostic Reagent Product Portfolio Table 110. Grifols Recent Development Table 111. Diasorin Company Information Table 112. Diasorin Business Overview Table 113. Diasorin Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Diasorin Molecular Diagnostic Reagent Product Portfolio Table 115. Diasorin Recent Development Table 116. Danaher Corporation Company Information Table 117. Danaher Corporation Business Overview Table 118. Danaher Corporation Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Danaher Corporation Molecular Diagnostic Reagent Product Portfolio Table 120. Danaher Corporation Recent Development Table 121. DaAn Gene Company Information Table 122. DaAn Gene Business Overview Table 123. DaAn Gene Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. DaAn Gene Molecular Diagnostic Reagent Product Portfolio Table 125. DaAn Gene Recent Development Table 126. Bio-Rad Laboratories Company Information Table 127. Bio-Rad Laboratories Business Overview Table 128. Bio-Rad Laboratories Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio Table 130. Bio-Rad Laboratories Recent Development Table 131. Biomérieux Sa Company Information Table 132. Biomérieux Sa Business Overview Table 133. Biomérieux Sa Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio Table 135. Biomérieux Sa Recent Development Table 136. Becton, Dickinson and Company Company Information Table 137. Becton, Dickinson and Company Business Overview Table 138. Becton, Dickinson and Company Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio Table 140. Becton, Dickinson and Company Recent Development Table 141. Agilent Technologies Company Information Table 142. Agilent Technologies Business Overview Table 143. Agilent Technologies Molecular Diagnostic Reagent Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Agilent Technologies Molecular Diagnostic Reagent Product Portfolio Table 145. Agilent Technologies Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Molecular Diagnostic Reagent Distributors List Table 149. Molecular Diagnostic Reagent Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Molecular Diagnostic Reagent Product Image Figure 2. Global Molecular Diagnostic Reagent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Diagnostic Reagent Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Diagnostic Reagent Sales (2021-2032) & (Tons) Figure 5. Global Molecular Diagnostic Reagent Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Molecular Diagnostic Reagent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polymerase Chain Reaction PCR Image Figure 9. Gene chip Image Figure 10. Gene Sequencing Image Figure 11. Molecular Hybridization Image Figure 12. Global Molecular Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Molecular Diagnostic Reagent Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Molecular Diagnostic Reagent Sales Market Share by Type (2021-2032) Figure 15. Global Molecular Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Molecular Diagnostic Reagent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Molecular Diagnostic Reagent Revenue Market Share by Type (2021-2032) Figure 18. Infectious Disease Diagnosis Image Figure 19. Genetic Diagnosis Image Figure 20. Blood Screening Image Figure 21. Other Image Figure 22. Global Molecular Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Molecular Diagnostic Reagent Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Molecular Diagnostic Reagent Sales Market Share by Application (2021-2032) Figure 25. Global Molecular Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Molecular Diagnostic Reagent Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Molecular Diagnostic Reagent Revenue Market Share by Application (2021-2032) Figure 28. North America Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 29. North America Molecular Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 30. U.S. Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Canada Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Mexico Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Europe Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Europe Molecular Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 35. Germany Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 36. France Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 37. U.K. Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Italy Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Netherlands Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Asia Pacific Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Asia Pacific Molecular Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 42. China Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Japan Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South Korea Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Southeast Asia Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 46. India Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 47. Australia Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South America, Middle East and Africa Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South America, Middle East and Africa Molecular Diagnostic Reagent Sales Market Share by Country (2021-2032) Figure 50. Brazil Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South Africa Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Saudi Arabia Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Turkey Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Argentina Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 55. UAE Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Egypt Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Chile Molecular Diagnostic Reagent Sales and Growth Rate (2021-2032) & (Tons) Figure 58. Global Molecular Diagnostic Reagent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Molecular Diagnostic Reagent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Molecular Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 61. North America Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Molecular Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 63. Europe Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Molecular Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Molecular Diagnostic Reagent Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Molecular Diagnostic Reagent Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Molecular Diagnostic Reagent Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Polymerase Chain Reaction PCR
  • Gene chip
  • Gene Sequencing
  • Molecular Hybridization
Applications
  • Infectious Disease Diagnosis
  • Genetic Diagnosis
  • Blood Screening
  • Other
Companies covered
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Merck KGaA
  • Roche Diagnostics
  • Siemens AG
  • Qiagen
  • Illumina
  • Hologic
  • Grifols
  • Diasorin
  • Danaher Corporation
  • DaAn Gene
  • Bio-Rad Laboratories
  • Biomérieux Sa
  • Becton, Dickinson and Company
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Diagnostic Reagent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Molecular Diagnostic Reagent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Molecular Diagnostic Reagent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Molecular Diagnostic Reagent Market Dynamics
  1. 2.1 Molecular Diagnostic Reagent Industry Trends
  2. 2.2 Molecular Diagnostic Reagent Industry Drivers
  3. 2.3 Molecular Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Molecular Diagnostic Reagent Industry Restraints
3 Molecular Diagnostic Reagent Market by Manufacturers
  1. 3.1 Global Molecular Diagnostic Reagent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Molecular Diagnostic Reagent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Molecular Diagnostic Reagent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Molecular Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Molecular Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Molecular Diagnostic Reagent Manufacturers, Product Type & Application
  7. 3.7 Global Molecular Diagnostic Reagent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Molecular Diagnostic Reagent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Molecular Diagnostic Reagent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Molecular Diagnostic Reagent Tier 1, Tier 2, and Tier 3
4 Molecular Diagnostic Reagent Market by Type
  1. 4.1 Molecular Diagnostic Reagent Type Introduction
  2. 4.1.1 Polymerase Chain Reaction PCR
  3. 4.1.2 Gene chip
  4. 4.1.3 Gene Sequencing
  5. 4.1.4 Molecular Hybridization
  6. 4.2 Global Molecular Diagnostic Reagent Sales by Type
  7. 4.2.1 Global Molecular Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Molecular Diagnostic Reagent Sales by Type (2021-2032)
  9. 4.2.3 Global Molecular Diagnostic Reagent Sales Market Share by Type (2021-2032)
  10. 4.3 Global Molecular Diagnostic Reagent Revenue by Type
  11. 4.3.1 Global Molecular Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Molecular Diagnostic Reagent Revenue by Type (2021-2032)
  13. 4.3.3 Global Molecular Diagnostic Reagent Revenue Market Share by Type (2021-2032)
5 Molecular Diagnostic Reagent Market by Application
  1. 5.1 Molecular Diagnostic Reagent Application Introduction
  2. 5.1.1 Infectious Disease Diagnosis
  3. 5.1.2 Genetic Diagnosis
  4. 5.1.3 Blood Screening
  5. 5.1.4 Other
  6. 5.2 Global Molecular Diagnostic Reagent Sales by Application
  7. 5.2.1 Global Molecular Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Molecular Diagnostic Reagent Sales by Application (2021-2032)
  9. 5.2.3 Global Molecular Diagnostic Reagent Sales Market Share by Application (2021-2032)
  10. 5.3 Global Molecular Diagnostic Reagent Revenue by Application
  11. 5.3.1 Global Molecular Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Molecular Diagnostic Reagent Revenue by Application (2021-2032)
  13. 5.3.3 Global Molecular Diagnostic Reagent Revenue Market Share by Application (2021-2032)
6 Global Molecular Diagnostic Reagent Sales by Region
  1. 6.1 Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Diagnostic Reagent Sales by Region (2021-2032)
  3. 6.2.1 Global Molecular Diagnostic Reagent Sales by Region (2021-2026)
  4. 6.2.2 Global Molecular Diagnostic Reagent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Molecular Diagnostic Reagent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Molecular Diagnostic Reagent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Molecular Diagnostic Reagent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Molecular Diagnostic Reagent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Molecular Diagnostic Reagent Revenue by Region
  1. 7.1 Global Molecular Diagnostic Reagent Revenue by Region
  2. 7.1.1 Global Molecular Diagnostic Reagent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Molecular Diagnostic Reagent Revenue by Region (2021-2026)
  4. 7.1.3 Global Molecular Diagnostic Reagent Revenue by Region (2027-2032)
  5. 7.1.4 Global Molecular Diagnostic Reagent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Molecular Diagnostic Reagent Revenue (2021-2032)
  8. 7.2.2 North America Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Molecular Diagnostic Reagent Revenue (2021-2032)
  11. 7.3.2 Europe Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Molecular Diagnostic Reagent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Molecular Diagnostic Reagent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Molecular Diagnostic Reagent Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Roche Diagnostics
  20. 8.4.1 Roche Diagnostics Company Information
  21. 8.4.2 Roche Diagnostics Business Overview
  22. 8.4.3 Roche Diagnostics Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio
  24. 8.4.5 Roche Diagnostics Recent Developments
  25. 8.5 Siemens AG
  26. 8.5.1 Siemens AG Company Information
  27. 8.5.2 Siemens AG Business Overview
  28. 8.5.3 Siemens AG Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens AG Molecular Diagnostic Reagent Product Portfolio
  30. 8.5.5 Siemens AG Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Molecular Diagnostic Reagent Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 Illumina
  38. 8.7.1 Illumina Company Information
  39. 8.7.2 Illumina Business Overview
  40. 8.7.3 Illumina Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Illumina Molecular Diagnostic Reagent Product Portfolio
  42. 8.7.5 Illumina Recent Developments
  43. 8.8 Hologic
  44. 8.8.1 Hologic Company Information
  45. 8.8.2 Hologic Business Overview
  46. 8.8.3 Hologic Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hologic Molecular Diagnostic Reagent Product Portfolio
  48. 8.8.5 Hologic Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Molecular Diagnostic Reagent Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 Diasorin
  56. 8.10.1 Diasorin Company Information
  57. 8.10.2 Diasorin Business Overview
  58. 8.10.3 Diasorin Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Diasorin Molecular Diagnostic Reagent Product Portfolio
  60. 8.10.5 Diasorin Recent Developments
  61. 8.11 Danaher Corporation
  62. 8.11.1 Danaher Corporation Company Information
  63. 8.11.2 Danaher Corporation Business Overview
  64. 8.11.3 Danaher Corporation Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Danaher Corporation Molecular Diagnostic Reagent Product Portfolio
  66. 8.11.5 Danaher Corporation Recent Developments
  67. 8.12 DaAn Gene
  68. 8.12.1 DaAn Gene Company Information
  69. 8.12.2 DaAn Gene Business Overview
  70. 8.12.3 DaAn Gene Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DaAn Gene Molecular Diagnostic Reagent Product Portfolio
  72. 8.12.5 DaAn Gene Recent Developments
  73. 8.13 Bio-Rad Laboratories
  74. 8.13.1 Bio-Rad Laboratories Company Information
  75. 8.13.2 Bio-Rad Laboratories Business Overview
  76. 8.13.3 Bio-Rad Laboratories Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio
  78. 8.13.5 Bio-Rad Laboratories Recent Developments
  79. 8.14 Biomérieux Sa
  80. 8.14.1 Biomérieux Sa Company Information
  81. 8.14.2 Biomérieux Sa Business Overview
  82. 8.14.3 Biomérieux Sa Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio
  84. 8.14.5 Biomérieux Sa Recent Developments
  85. 8.15 Becton, Dickinson and Company
  86. 8.15.1 Becton, Dickinson and Company Company Information
  87. 8.15.2 Becton, Dickinson and Company Business Overview
  88. 8.15.3 Becton, Dickinson and Company Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio
  90. 8.15.5 Becton, Dickinson and Company Recent Developments
  91. 8.16 Agilent Technologies
  92. 8.16.1 Agilent Technologies Company Information
  93. 8.16.2 Agilent Technologies Business Overview
  94. 8.16.3 Agilent Technologies Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Agilent Technologies Molecular Diagnostic Reagent Product Portfolio
  96. 8.16.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molecular Diagnostic Reagent Value Chain Analysis
  2. 9.1.1 Molecular Diagnostic Reagent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molecular Diagnostic Reagent Production Mode & Process
  6. 9.2 Molecular Diagnostic Reagent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molecular Diagnostic Reagent Distributors
  9. 9.2.3 Molecular Diagnostic Reagent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.